Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Amortizatization of Intangibles (2016 - 2025)

Icu Medical (ICUI) has disclosed Amortizatization of Intangibles for 17 consecutive years, with $3.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Amortizatization of Intangibles fell 34.18% year-over-year to $3.5 million, compared with a TTM value of $17.3 million through Dec 2025, down 19.18%, and an annual FY2025 reading of $17.3 million, down 19.18% over the prior year.
  • Amortizatization of Intangibles was $3.5 million for Q4 2025 at Icu Medical, down from $4.4 million in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $9.1 million in Q4 2021 and bottomed at -$2.0 million in Q2 2021.
  • Average Amortizatization of Intangibles over 5 years is $4.7 million, with a median of $5.3 million recorded in 2024.
  • Peak annual rise in Amortizatization of Intangibles hit 6876.47% in 2021, while the deepest fall reached 144.69% in 2021.
  • Year by year, Amortizatization of Intangibles stood at $9.1 million in 2021, then crashed by 30.96% to $6.3 million in 2022, then fell by 14.39% to $5.4 million in 2023, then dropped by 0.58% to $5.3 million in 2024, then plummeted by 34.18% to $3.5 million in 2025.
  • Business Quant data shows Amortizatization of Intangibles for ICUI at $3.5 million in Q4 2025, $4.4 million in Q3 2025, and $4.8 million in Q2 2025.